This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The House COVID-19 Subcommittee hears testimony from a nationwide expert about the danger of the B.1.1.7 variant from Britain.
A few scientists say that two small studies indicate that a decades-old antidepressant that costs $10 for a two-week course could be used to fight COVID.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The contract aligns OHSU with other academic medical institutions on the West Coast and marks the third AFSCME bargaining unit at the university.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Seven federally qualified health centers can administer vaccines to patients even if they're not eligible to get vulnerable communities vaccinated sooner.
House Bill 2421, sponsored by Reps. Raquel Moore-Green and Andrea Salinas, would establish a Chronic Kidney Disease Task Force responsible for developing an education and prevention campaign.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
If the proposal to enshrine affordable health care in the state constitution passes the Legislature, it will be put before voters in November 2022.
Some Oregonians said a Legacy Health website for scheduling vaccine appointments would not let them complete a reservation Monday morning.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Three pharmacies in charge of vaccinating congregate care facilities signed up very few adult care homes, leaving staff to scramble to get their residents protected against COVID-19.
Already disproportionately affected by the virus, Black and Brown communities have thus far been receiving vaccines at much lower rates than their white counterparts.
Researchers at Fred Hutchinson Cancer Research Center in Seattle found that race and ethnicity data were often absent in trial results.
